Keyword: Google Life Sciences

Verily CTO talks GSK, Google and why biology must meet technology

As Alphabet subsidiary Verily announced a major $715 million, 7-year research deal with GlaxoSmithKline this week--which sees the two create a new JV company called Galvani Bioelectronics--FierceMedicalDevices’ Ben Adams speaks to its chief technology officer, Brian Otis, about how this deal will shape the company’s future, and the future of medicine.